|
|
 |
|
Viewing report
|
|
|
|
Amgen Inc. (AMGN) - Financial and Strategic SWOT Analysis Review
GlobalData, Feb 2012, Pages: 57
Amgen Inc. (AMGN) - Financial and Strategic SWOT Analysis Review
Summary
Amgen Inc. (Amgen) is a biotechnology company. It focuses on the discovery, development, manufacture and marketing of human therapeutics based on advances in cellular and molecular biology. The company markets therapeutic products in the field of supportive cancer care, nephrology and inflammation. It mainly focuses on research and development (R&D) activities to develop novel human therapeutics in the areas of oncology, hematology, inflammation, bone, nephrology and general medicine. The products that the company offers include Aranesp, Neulasta, Prolia, NEUPOGEN, EPOGEN and ENBREL. Geographically, the company operates in the US, Canada, Europe, Australia and Asia.
The key business strategies of the company include enhanced focus on increasing reputation for inventive and innovative thinking, flexibility and customer focus. It mainly concentrates to serve diversified customers and markets and also assures a continuous, innovative and distinctive flow. It also aims to maintain its existing partnerships and to enter new collaborative agreements to fuel its services. Recently, the company acquired a biotechnology company Micromet, to strengthen the innovative oncology asset. Amgen is headquartered in California, the US.
Amgen Inc. Key Recent Developments
Feb 14, 2012: Amgen Names Michael Severino As Senior Vice President And Corporate Chief Medical Officer
Jan 26, 2012: Amgen Reports Revenue Of $3.97 Billion In Q4 2011
Dec 15, 2011: Amgen Announces Senior Management Changes
Nov 14, 2011: ImmunoGen Earns Milestone Payment From Amgen With IND Achievement For Second TAP Compound
Oct 24, 2011: Amgen Reports Revenue Of $3.94 Billion In Q3 2011
This comprehensive SWOT profile of Amgen Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Key Words
Amgen Inc., SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
Customers who bought this item also bought
GlaxoSmithKline plc (GSK) - Financial and Strategic SWOT Analysis Review
Life Technologies Corporation (LIFE) - Financial and Strategic SWOT Analysis Review
Alexza Pharmaceuticals, Inc. (ALXA) - Financial and Strategic SWOT Analysis Review
Sunovion Pharmaceuticals Inc. - Strategic SWOT Analysis Review
Hospira, Inc. (HSP) - Financial and Strategic SWOT Analysis Review
Alnylam Pharmaceuticals, Inc (ALNY) - Financial and Strategic SWOT Analysis Review
Nektar Therapeutics (NKTR) - Financial and Strategic SWOT Analysis Review
Covidien plc (COV) - Financial and Strategic SWOT Analysis Review
Syneron Medical Ltd. (ELOS) - Financial and Strategic SWOT Analysis Review
Novartis AG (NOVN) - Financial and Strategic SWOT Analysis Review
|
|
|
|
